ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,581Medicare Part D Prescriptions Filled, Including Refills

Rank: 525 out of 1456

$351K Total Retail Price of All Prescriptions

Rank: 637 out of 1456

316 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
35% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

4% of this provider’s 316 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

4% of this provider’s 6,779 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
AMLODIPINE BESYLATE 308 278 1 1
LISINOPRIL 308 288 1 3
METFORMIN HCL 284 251 3 8
SIMVASTATIN 242 238 4 2
ATENOLOL 218 199 5 18
EVISTA 191 186 6 113
GLIMEPIRIDE 190 166 7 33
SPIRONOLACTONE-HCTZ 177 148 8 267
HYDROCHLOROTHIAZIDE 168 143 9 10
TRIAMTERENE-HCTZ 158 158 10 49
DIGOXIN 154 154 11 62
BISOPROLOL-HYDROCHLOROTHIAZIDE 152 127 12 93
ATORVASTATIN CALCIUM 144 137 13 11
AMLODIPINE BESYLATE-BENAZEPRIL 135 126 14 61
DILTIAZEM 24HR ER 117 108 15 126
IBUPROFEN 103 80 16 103
METOPROLOL TARTRATE 95 76 17 12
HYDRALAZINE HCL 92 78 18 48
PRAVASTATIN SODIUM 91 86 19 9
CLONIDINE HCL 88 69 20 39
LEVOTHYROXINE SODIUM 88 67 20 4
AMITRIPTYLINE HCL 85 79 R 22 70
SPIRONOLACTONE 82 67 23 73
AZITHROMYCIN 81 71 24 44
TAMSULOSIN HCL 78 78 25 34
NAMENDA 76 76 26 38
VERAPAMIL ER 74 74 27 82
GABAPENTIN 73 60 28 13
ALLOPURINOL 70 66 29 31
TORSEMIDE 67 64 30 145
ALENDRONATE SODIUM 67 62 30 36
GLYBURIDE-METFORMIN HCL 66 60 R 32 119
COUMADIN 64 54 33 225
DONEPEZIL HCL 64 64 33 29
METOPROLOL SUCCINATE 63 59 35 19
NIFEDIPINE ER 63 51 35 81
RANITIDINE HCL 63 57 35 27
ZOLPIDEM TARTRATE 59 52 38 14
LISINOPRIL-HYDROCHLOROTHIAZIDE 57 39 39 24
CARVEDILOL 55 44 40 20
ACTOS 52 49 41 115
POTASSIUM CHLORIDE 52 52 41 15
FLECAINIDE ACETATE 51 51 43 327
CYCLOBENZAPRINE HCL 51 43 R 43 66
CLOPIDOGREL 50 46 45 32
TRAMADOL HCL 50 33 45 17
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 28, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.